Table 3.

Study characteristics for studies examining the relationship between PWV and mortality/morbidity outcomes

StudySample sizeAge (years)Female (%)CKD Stage*DM (%)CVD (%)PWV (m/s)OutcomeComparisonEffect estimate (95% CI)Follow-up duration (months)
Dimkovic et al. [53]22058.946Hemodialysis11.8209.68 ± 2.12CV mortality
  • Continuous

  • (per 1 m/s increment)

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.192 (1.076–1.320)

76
Premuzic et al. [51]966650HemodialysisNANA10.5 ± 1.9CV mortality
  • Quartiles (m/s):

  • PWV: 7.5 m/s

  • PWV: 9.0 m/s

  • PWV: 11.1 m/s

  • CV mortality (Tertile 3 versus Tertile 1):

  • OR: 20.49 (4.45–94.39)

25
Nemcsik et al. [50]1006652Non-hemodialysis4464
  • 11.26

  • (8.9–14.9)

  • CV events

  • (CV death, heart failure, stroke, transient ischemic attack and peripheral artery disease with intervention)

  • Tertiles (m/s):

  • PWV: 6.6–9.8 m/s

  • PWV: 9.9–13.0 m/s

  • PWV: 13.2–27.2 m/s

  • CV events (Tertile 3 versus Tertile 1):

  • HR: 1.284 (0.386–4.273)

NA
Townsend et al. [52]279559.943.6Non-hemodialysis47.3NANAAll-cause mortality
  • Tertiles (m/s):

  • PWV: <7.9 m/s

  • PWV: 7.9–10.3 m/s

  • PWV: >10.3 m/s

  • Adjusted all-cause mortality

  • (Tertile 3 versus Tertile 1)

  • HR: 1.72 (1.24–2.38)

65
Sarafidis et al. [43]17063.869Hemodialysis54NA9.4 (2.2)
  • All-cause mortality

  • CV mortality

  • Quartiles (m/s):

  • PWV: 6.75 ± 0.77

  • PWV: 8.53 ± 0.57

  • PWV: 10.2 ± 0.46

  • PWV: 12.28 ± 0.96

  • All-cause mortality (Quartile 4 versus Quartile 1):

  • HR: 8.495 (1.912–37.740)

  • CV mortality (Quartile 4 versus Quartile 1):

  • HR: 6.745 (1.472–30.912)

28
Chiu et al. [44]21964.232.3Hemodialysis39.4NA8.81 (2.08)
  • All-cause mortality

  • CV mortality

  • CV events

  • (myocardial infarction,

  • angina, hospitalization due to heart failure or arrhythmia, coronary

  • revascularization and cardiac death)

  • Continuous

  • (per 1 m/s increment)

  • All-cause mortality (per 1 m/s PWV increment):

  • Adjusted HR: 1.23 (1.03–1.47)

  • CV mortality (per 1 m/s PWV increment):

  • Unadjusted HR: 1.18 (0.89–1.39), P = 0.034

  • CV events (per 1 m/s PWV increment):

  • Unadjusted HR: 1.02 (0.88–1.17), P = 0.802

28
He et al. [15]1285654Hemodialysis13.3NANRAll-cause mortality
  • Continuous

  • (per 1 m/s increment)

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.265 (1.022–1.567), P = 0.031

24
Baumann et al. [45]13559.254Non-hemodialysis47NA10.5 (3.0)All-cause mortality
  • PWV: <10 m/s

  • PWV: >10m/s

  • All-cause mortality:

  • HR: 5.1 (1.1–22.9)

42
Avramovski et al. [46]8059.334Hemodialysis20NA12.5 (2.01)
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • PWV: <11.8 m/s

  • PWV: >11.8 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.299 (1.09–1.54)

  • All-cause mortality (PWV >11.8 m/s):

  • RR: 4.3 (1.6–11.51), P = 0.0037

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.4284 (1.696–1.757)

  • CV mortality (PWV >11.8 m/s):

  • RR: 14.36 (2.01–102.77), P = 0.008

36
Karras et al. [18]43959.826Non-hemodialysis272811.9 (3.4)
  • All-cause mortality

  • CV events

  • (coronary heart disease, stroke, peripheral

  • arterial disease and heart failure)

  • PWV: <12 m/s

  • PWV: >12 m/s

  • All-cause mortality:

  • HR: 3.3 (1.9–5.7)

  • CV events:

  • Per 1 SD, HR: 1.35 (1.05–1.75)

56
Othmane et al. [47]9863.439Hemodialysis40.860.211.2 (3.25)CV mortality
  • Continuous

  • (per 1 m/s increment)

  • Tertile:

  • PWV: 3.8–9.5 m/s

  • PWV: 9.6–12.1 m/s

  • PWV: 12.5–23.8 m/s

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.34 (1.17–1.53), P < 0.001

29
Zoungas et al. [25]2075732Non-hemodialysisNA72NA
  • CV events

  • (cardiac death and acute myocardial infarction, stroke, unstable angina,

  • coronary revascularization and peripheral vascular

  • events)

  • PWV: <9.9 m/s

  • PWV: >9.9 m/s

  • CV events

  • HR: 3.38 (1.70–6.73)

60
Shoji et al. [48]25655.459Hemodialysis19.5NA8.64 ± 2.16
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • PWV: <8.2 m/s

  • PWV: >8.2 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.156 (1.032–1.295), P < 0.05

  • CVmortality (per 1 m/s PWV increment):

  • HR: 1.152 (0.978–1.359), P = 0.079–0.090

63
Blacher et al. [49]24151.539Hemodialysis72411.1 ± 3.1
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • Tertiles:

  • PWV: <9.4 m/s

  • PWV: 9.4–12 m/s

  • PWV: >12 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • OR 1.39 (1.19–1.62)

  • All-cause mortality (Tertile 3 versus Tertile 1):

  • OR 5.4 (2.4–11.9)

  • CV mortality (Tertile 3 versus Tertile 1):

  • OR 5.9 (2.3–15.5)

72
StudySample sizeAge (years)Female (%)CKD Stage*DM (%)CVD (%)PWV (m/s)OutcomeComparisonEffect estimate (95% CI)Follow-up duration (months)
Dimkovic et al. [53]22058.946Hemodialysis11.8209.68 ± 2.12CV mortality
  • Continuous

  • (per 1 m/s increment)

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.192 (1.076–1.320)

76
Premuzic et al. [51]966650HemodialysisNANA10.5 ± 1.9CV mortality
  • Quartiles (m/s):

  • PWV: 7.5 m/s

  • PWV: 9.0 m/s

  • PWV: 11.1 m/s

  • CV mortality (Tertile 3 versus Tertile 1):

  • OR: 20.49 (4.45–94.39)

25
Nemcsik et al. [50]1006652Non-hemodialysis4464
  • 11.26

  • (8.9–14.9)

  • CV events

  • (CV death, heart failure, stroke, transient ischemic attack and peripheral artery disease with intervention)

  • Tertiles (m/s):

  • PWV: 6.6–9.8 m/s

  • PWV: 9.9–13.0 m/s

  • PWV: 13.2–27.2 m/s

  • CV events (Tertile 3 versus Tertile 1):

  • HR: 1.284 (0.386–4.273)

NA
Townsend et al. [52]279559.943.6Non-hemodialysis47.3NANAAll-cause mortality
  • Tertiles (m/s):

  • PWV: <7.9 m/s

  • PWV: 7.9–10.3 m/s

  • PWV: >10.3 m/s

  • Adjusted all-cause mortality

  • (Tertile 3 versus Tertile 1)

  • HR: 1.72 (1.24–2.38)

65
Sarafidis et al. [43]17063.869Hemodialysis54NA9.4 (2.2)
  • All-cause mortality

  • CV mortality

  • Quartiles (m/s):

  • PWV: 6.75 ± 0.77

  • PWV: 8.53 ± 0.57

  • PWV: 10.2 ± 0.46

  • PWV: 12.28 ± 0.96

  • All-cause mortality (Quartile 4 versus Quartile 1):

  • HR: 8.495 (1.912–37.740)

  • CV mortality (Quartile 4 versus Quartile 1):

  • HR: 6.745 (1.472–30.912)

28
Chiu et al. [44]21964.232.3Hemodialysis39.4NA8.81 (2.08)
  • All-cause mortality

  • CV mortality

  • CV events

  • (myocardial infarction,

  • angina, hospitalization due to heart failure or arrhythmia, coronary

  • revascularization and cardiac death)

  • Continuous

  • (per 1 m/s increment)

  • All-cause mortality (per 1 m/s PWV increment):

  • Adjusted HR: 1.23 (1.03–1.47)

  • CV mortality (per 1 m/s PWV increment):

  • Unadjusted HR: 1.18 (0.89–1.39), P = 0.034

  • CV events (per 1 m/s PWV increment):

  • Unadjusted HR: 1.02 (0.88–1.17), P = 0.802

28
He et al. [15]1285654Hemodialysis13.3NANRAll-cause mortality
  • Continuous

  • (per 1 m/s increment)

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.265 (1.022–1.567), P = 0.031

24
Baumann et al. [45]13559.254Non-hemodialysis47NA10.5 (3.0)All-cause mortality
  • PWV: <10 m/s

  • PWV: >10m/s

  • All-cause mortality:

  • HR: 5.1 (1.1–22.9)

42
Avramovski et al. [46]8059.334Hemodialysis20NA12.5 (2.01)
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • PWV: <11.8 m/s

  • PWV: >11.8 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.299 (1.09–1.54)

  • All-cause mortality (PWV >11.8 m/s):

  • RR: 4.3 (1.6–11.51), P = 0.0037

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.4284 (1.696–1.757)

  • CV mortality (PWV >11.8 m/s):

  • RR: 14.36 (2.01–102.77), P = 0.008

36
Karras et al. [18]43959.826Non-hemodialysis272811.9 (3.4)
  • All-cause mortality

  • CV events

  • (coronary heart disease, stroke, peripheral

  • arterial disease and heart failure)

  • PWV: <12 m/s

  • PWV: >12 m/s

  • All-cause mortality:

  • HR: 3.3 (1.9–5.7)

  • CV events:

  • Per 1 SD, HR: 1.35 (1.05–1.75)

56
Othmane et al. [47]9863.439Hemodialysis40.860.211.2 (3.25)CV mortality
  • Continuous

  • (per 1 m/s increment)

  • Tertile:

  • PWV: 3.8–9.5 m/s

  • PWV: 9.6–12.1 m/s

  • PWV: 12.5–23.8 m/s

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.34 (1.17–1.53), P < 0.001

29
Zoungas et al. [25]2075732Non-hemodialysisNA72NA
  • CV events

  • (cardiac death and acute myocardial infarction, stroke, unstable angina,

  • coronary revascularization and peripheral vascular

  • events)

  • PWV: <9.9 m/s

  • PWV: >9.9 m/s

  • CV events

  • HR: 3.38 (1.70–6.73)

60
Shoji et al. [48]25655.459Hemodialysis19.5NA8.64 ± 2.16
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • PWV: <8.2 m/s

  • PWV: >8.2 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.156 (1.032–1.295), P < 0.05

  • CVmortality (per 1 m/s PWV increment):

  • HR: 1.152 (0.978–1.359), P = 0.079–0.090

63
Blacher et al. [49]24151.539Hemodialysis72411.1 ± 3.1
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • Tertiles:

  • PWV: <9.4 m/s

  • PWV: 9.4–12 m/s

  • PWV: >12 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • OR 1.39 (1.19–1.62)

  • All-cause mortality (Tertile 3 versus Tertile 1):

  • OR 5.4 (2.4–11.9)

  • CV mortality (Tertile 3 versus Tertile 1):

  • OR 5.9 (2.3–15.5)

72

DM, diabetes mellitus; OR, odds ratio.

Table 3.

Study characteristics for studies examining the relationship between PWV and mortality/morbidity outcomes

StudySample sizeAge (years)Female (%)CKD Stage*DM (%)CVD (%)PWV (m/s)OutcomeComparisonEffect estimate (95% CI)Follow-up duration (months)
Dimkovic et al. [53]22058.946Hemodialysis11.8209.68 ± 2.12CV mortality
  • Continuous

  • (per 1 m/s increment)

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.192 (1.076–1.320)

76
Premuzic et al. [51]966650HemodialysisNANA10.5 ± 1.9CV mortality
  • Quartiles (m/s):

  • PWV: 7.5 m/s

  • PWV: 9.0 m/s

  • PWV: 11.1 m/s

  • CV mortality (Tertile 3 versus Tertile 1):

  • OR: 20.49 (4.45–94.39)

25
Nemcsik et al. [50]1006652Non-hemodialysis4464
  • 11.26

  • (8.9–14.9)

  • CV events

  • (CV death, heart failure, stroke, transient ischemic attack and peripheral artery disease with intervention)

  • Tertiles (m/s):

  • PWV: 6.6–9.8 m/s

  • PWV: 9.9–13.0 m/s

  • PWV: 13.2–27.2 m/s

  • CV events (Tertile 3 versus Tertile 1):

  • HR: 1.284 (0.386–4.273)

NA
Townsend et al. [52]279559.943.6Non-hemodialysis47.3NANAAll-cause mortality
  • Tertiles (m/s):

  • PWV: <7.9 m/s

  • PWV: 7.9–10.3 m/s

  • PWV: >10.3 m/s

  • Adjusted all-cause mortality

  • (Tertile 3 versus Tertile 1)

  • HR: 1.72 (1.24–2.38)

65
Sarafidis et al. [43]17063.869Hemodialysis54NA9.4 (2.2)
  • All-cause mortality

  • CV mortality

  • Quartiles (m/s):

  • PWV: 6.75 ± 0.77

  • PWV: 8.53 ± 0.57

  • PWV: 10.2 ± 0.46

  • PWV: 12.28 ± 0.96

  • All-cause mortality (Quartile 4 versus Quartile 1):

  • HR: 8.495 (1.912–37.740)

  • CV mortality (Quartile 4 versus Quartile 1):

  • HR: 6.745 (1.472–30.912)

28
Chiu et al. [44]21964.232.3Hemodialysis39.4NA8.81 (2.08)
  • All-cause mortality

  • CV mortality

  • CV events

  • (myocardial infarction,

  • angina, hospitalization due to heart failure or arrhythmia, coronary

  • revascularization and cardiac death)

  • Continuous

  • (per 1 m/s increment)

  • All-cause mortality (per 1 m/s PWV increment):

  • Adjusted HR: 1.23 (1.03–1.47)

  • CV mortality (per 1 m/s PWV increment):

  • Unadjusted HR: 1.18 (0.89–1.39), P = 0.034

  • CV events (per 1 m/s PWV increment):

  • Unadjusted HR: 1.02 (0.88–1.17), P = 0.802

28
He et al. [15]1285654Hemodialysis13.3NANRAll-cause mortality
  • Continuous

  • (per 1 m/s increment)

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.265 (1.022–1.567), P = 0.031

24
Baumann et al. [45]13559.254Non-hemodialysis47NA10.5 (3.0)All-cause mortality
  • PWV: <10 m/s

  • PWV: >10m/s

  • All-cause mortality:

  • HR: 5.1 (1.1–22.9)

42
Avramovski et al. [46]8059.334Hemodialysis20NA12.5 (2.01)
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • PWV: <11.8 m/s

  • PWV: >11.8 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.299 (1.09–1.54)

  • All-cause mortality (PWV >11.8 m/s):

  • RR: 4.3 (1.6–11.51), P = 0.0037

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.4284 (1.696–1.757)

  • CV mortality (PWV >11.8 m/s):

  • RR: 14.36 (2.01–102.77), P = 0.008

36
Karras et al. [18]43959.826Non-hemodialysis272811.9 (3.4)
  • All-cause mortality

  • CV events

  • (coronary heart disease, stroke, peripheral

  • arterial disease and heart failure)

  • PWV: <12 m/s

  • PWV: >12 m/s

  • All-cause mortality:

  • HR: 3.3 (1.9–5.7)

  • CV events:

  • Per 1 SD, HR: 1.35 (1.05–1.75)

56
Othmane et al. [47]9863.439Hemodialysis40.860.211.2 (3.25)CV mortality
  • Continuous

  • (per 1 m/s increment)

  • Tertile:

  • PWV: 3.8–9.5 m/s

  • PWV: 9.6–12.1 m/s

  • PWV: 12.5–23.8 m/s

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.34 (1.17–1.53), P < 0.001

29
Zoungas et al. [25]2075732Non-hemodialysisNA72NA
  • CV events

  • (cardiac death and acute myocardial infarction, stroke, unstable angina,

  • coronary revascularization and peripheral vascular

  • events)

  • PWV: <9.9 m/s

  • PWV: >9.9 m/s

  • CV events

  • HR: 3.38 (1.70–6.73)

60
Shoji et al. [48]25655.459Hemodialysis19.5NA8.64 ± 2.16
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • PWV: <8.2 m/s

  • PWV: >8.2 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.156 (1.032–1.295), P < 0.05

  • CVmortality (per 1 m/s PWV increment):

  • HR: 1.152 (0.978–1.359), P = 0.079–0.090

63
Blacher et al. [49]24151.539Hemodialysis72411.1 ± 3.1
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • Tertiles:

  • PWV: <9.4 m/s

  • PWV: 9.4–12 m/s

  • PWV: >12 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • OR 1.39 (1.19–1.62)

  • All-cause mortality (Tertile 3 versus Tertile 1):

  • OR 5.4 (2.4–11.9)

  • CV mortality (Tertile 3 versus Tertile 1):

  • OR 5.9 (2.3–15.5)

72
StudySample sizeAge (years)Female (%)CKD Stage*DM (%)CVD (%)PWV (m/s)OutcomeComparisonEffect estimate (95% CI)Follow-up duration (months)
Dimkovic et al. [53]22058.946Hemodialysis11.8209.68 ± 2.12CV mortality
  • Continuous

  • (per 1 m/s increment)

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.192 (1.076–1.320)

76
Premuzic et al. [51]966650HemodialysisNANA10.5 ± 1.9CV mortality
  • Quartiles (m/s):

  • PWV: 7.5 m/s

  • PWV: 9.0 m/s

  • PWV: 11.1 m/s

  • CV mortality (Tertile 3 versus Tertile 1):

  • OR: 20.49 (4.45–94.39)

25
Nemcsik et al. [50]1006652Non-hemodialysis4464
  • 11.26

  • (8.9–14.9)

  • CV events

  • (CV death, heart failure, stroke, transient ischemic attack and peripheral artery disease with intervention)

  • Tertiles (m/s):

  • PWV: 6.6–9.8 m/s

  • PWV: 9.9–13.0 m/s

  • PWV: 13.2–27.2 m/s

  • CV events (Tertile 3 versus Tertile 1):

  • HR: 1.284 (0.386–4.273)

NA
Townsend et al. [52]279559.943.6Non-hemodialysis47.3NANAAll-cause mortality
  • Tertiles (m/s):

  • PWV: <7.9 m/s

  • PWV: 7.9–10.3 m/s

  • PWV: >10.3 m/s

  • Adjusted all-cause mortality

  • (Tertile 3 versus Tertile 1)

  • HR: 1.72 (1.24–2.38)

65
Sarafidis et al. [43]17063.869Hemodialysis54NA9.4 (2.2)
  • All-cause mortality

  • CV mortality

  • Quartiles (m/s):

  • PWV: 6.75 ± 0.77

  • PWV: 8.53 ± 0.57

  • PWV: 10.2 ± 0.46

  • PWV: 12.28 ± 0.96

  • All-cause mortality (Quartile 4 versus Quartile 1):

  • HR: 8.495 (1.912–37.740)

  • CV mortality (Quartile 4 versus Quartile 1):

  • HR: 6.745 (1.472–30.912)

28
Chiu et al. [44]21964.232.3Hemodialysis39.4NA8.81 (2.08)
  • All-cause mortality

  • CV mortality

  • CV events

  • (myocardial infarction,

  • angina, hospitalization due to heart failure or arrhythmia, coronary

  • revascularization and cardiac death)

  • Continuous

  • (per 1 m/s increment)

  • All-cause mortality (per 1 m/s PWV increment):

  • Adjusted HR: 1.23 (1.03–1.47)

  • CV mortality (per 1 m/s PWV increment):

  • Unadjusted HR: 1.18 (0.89–1.39), P = 0.034

  • CV events (per 1 m/s PWV increment):

  • Unadjusted HR: 1.02 (0.88–1.17), P = 0.802

28
He et al. [15]1285654Hemodialysis13.3NANRAll-cause mortality
  • Continuous

  • (per 1 m/s increment)

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.265 (1.022–1.567), P = 0.031

24
Baumann et al. [45]13559.254Non-hemodialysis47NA10.5 (3.0)All-cause mortality
  • PWV: <10 m/s

  • PWV: >10m/s

  • All-cause mortality:

  • HR: 5.1 (1.1–22.9)

42
Avramovski et al. [46]8059.334Hemodialysis20NA12.5 (2.01)
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • PWV: <11.8 m/s

  • PWV: >11.8 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.299 (1.09–1.54)

  • All-cause mortality (PWV >11.8 m/s):

  • RR: 4.3 (1.6–11.51), P = 0.0037

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.4284 (1.696–1.757)

  • CV mortality (PWV >11.8 m/s):

  • RR: 14.36 (2.01–102.77), P = 0.008

36
Karras et al. [18]43959.826Non-hemodialysis272811.9 (3.4)
  • All-cause mortality

  • CV events

  • (coronary heart disease, stroke, peripheral

  • arterial disease and heart failure)

  • PWV: <12 m/s

  • PWV: >12 m/s

  • All-cause mortality:

  • HR: 3.3 (1.9–5.7)

  • CV events:

  • Per 1 SD, HR: 1.35 (1.05–1.75)

56
Othmane et al. [47]9863.439Hemodialysis40.860.211.2 (3.25)CV mortality
  • Continuous

  • (per 1 m/s increment)

  • Tertile:

  • PWV: 3.8–9.5 m/s

  • PWV: 9.6–12.1 m/s

  • PWV: 12.5–23.8 m/s

  • CV mortality (per 1 m/s PWV increment):

  • HR: 1.34 (1.17–1.53), P < 0.001

29
Zoungas et al. [25]2075732Non-hemodialysisNA72NA
  • CV events

  • (cardiac death and acute myocardial infarction, stroke, unstable angina,

  • coronary revascularization and peripheral vascular

  • events)

  • PWV: <9.9 m/s

  • PWV: >9.9 m/s

  • CV events

  • HR: 3.38 (1.70–6.73)

60
Shoji et al. [48]25655.459Hemodialysis19.5NA8.64 ± 2.16
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • PWV: <8.2 m/s

  • PWV: >8.2 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • HR: 1.156 (1.032–1.295), P < 0.05

  • CVmortality (per 1 m/s PWV increment):

  • HR: 1.152 (0.978–1.359), P = 0.079–0.090

63
Blacher et al. [49]24151.539Hemodialysis72411.1 ± 3.1
  • All-cause mortality

  • CV mortality

  • Continuous

  • (per 1 m/s increment)

  • Tertiles:

  • PWV: <9.4 m/s

  • PWV: 9.4–12 m/s

  • PWV: >12 m/s

  • All-cause mortality (per 1 m/s PWV increment):

  • OR 1.39 (1.19–1.62)

  • All-cause mortality (Tertile 3 versus Tertile 1):

  • OR 5.4 (2.4–11.9)

  • CV mortality (Tertile 3 versus Tertile 1):

  • OR 5.9 (2.3–15.5)

72

DM, diabetes mellitus; OR, odds ratio.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close